The Optimal Cutoff Value of Neutrophil/Lymphocyte Ratio for Severe Grades of Diabetic Retinopathy

The Optimal Cutoff Value of Neutrophil/Lymphocyte Ratio for Severe Grades of Diabetic Retinopathy

INTRODUCTION[|]The aim of this study was to define the optimal cutoff value of the neutrophil/lymphocyte ratio (NLR) to predict severe grades of diabetic retinopathy (DR). [¤]METHODS[|]A total of 40 patients with proliferative DR (PDR) and 40 patients with severe non-proliferative DR (NPDR) were inc...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Çağrı İlhan, Mehmet Çıtırık, Mehmet Murat Uzel, Kemal Tekin
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	KARE Publishing 2019-08-01
Reeks:	Beyoglu Eye Journal
Onderwerpen:	neutrophil/lymphocyte ratio proliferative diabetic retinopathy severe nonproliferative diabetic retinopathy.
Online toegang:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=beyoglu&un=BEJ-85698

Gelijkaardige items

Study of the association of lipocalin-1 in tears with the progression of diabetic retinopathy: Cross-sectional comparative study
door: Rahul Bhatia, et al.
Gepubliceerd in: (2023-01-01)

Evaluation of retrobulbar circulation in diabetic patients using color Doppler imaging
door: Amit Shankhwar, et al.
Gepubliceerd in: (2023-01-01)

To study the role of hematological biomarkers in type 2 diabetes patients with diabetic retinopathy
door: Ishita Bajaj, et al.
Gepubliceerd in: (2023-01-01)

Developing and Validating Models to Predict Progression to Proliferative Diabetic Retinopathy
door: Yian Guo, MS, et al.
Gepubliceerd in: (2023-06-01)

Standard versus widefield angiography in detecting new vessels in proliferative diabetic retinopathy
door: S Sindhu, et al.
Gepubliceerd in: (2017-01-01)

Diabetic retinopathy awareness and associations with multiple comorbidities: Insights from DIAMOND Study
door: Kiran Shah, et al.
Gepubliceerd in: (2018-01-01)

Prevalence of diabetic retinopathy, proliferative diabetic retinopathy and non-proliferative diabetic retinopathy in Asian T2DM patients: a systematic review and Meta-analysis
door: Qian-Hui Yang, et al.
Gepubliceerd in: (2019-02-01)

Choroidal thickness in type 2 diabetic patients with various stages of diabetic macular edema and retinopathy: A prospective study from central India
door: Shilpi H Narnaware, et al.
Gepubliceerd in: (2019-01-01)

Relation between 25-hydroxy vitamin D and diabetic retinopathy in Egyptian patients with type 2 diabetes mellitus
door: Mervat E. Elwakeel, et al.
Gepubliceerd in: (2024-01-01)

A Nonrandomized Phase 2 Trial of EG-Mirotin, a Novel, First-in-Class, Subcutaneously Deliverable Peptide Drug for Nonproliferative Diabetic Retinopathy
door: Seunghoon Yoo, et al.
Gepubliceerd in: (2023-01-01)

Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema
door: Ning Zhao, et al.
Gepubliceerd in: (2022-04-01)

An institution-based cross-sectional study on the prevalence of diabetic retinopathy from Kolkata
door: Mita Saha Dutta Chowdhury, et al.
Gepubliceerd in: (2021-01-01)

The Impact of Total Physical Activity on Microvascular Complications in Type 1 Diabetes Mellitus Patients
door: Katarina Turčinović, et al.
Gepubliceerd in: (2023-01-01)

Frequency of Diabetic Retinopathy in Karachi, Pakistan: A Hospital Based Study
door: saba Alkhairy, et al.
Gepubliceerd in: (2015-08-01)

Frequency of Diabetic Retinopathy in Karachi, Pakistan: A Hospital Based Study
door: saba Alkhairy, et al.
Gepubliceerd in: (2015-08-01)

Frequency of Diabetic Retinopathy in Karachi, Pakistan: A Hospital Based Study
door: Saba Alkhairy, et al.
Gepubliceerd in: (2015-09-01)

Pattern of diabetic retinopathy in a tertiary healthcare facility in Southern Nigeria
door: Chineze Thelma Agweye, et al.
Gepubliceerd in: (2021-01-01)

Diabetic Retinopathy –Incidence And Risk Factors In A Community Setting- A Longitudinal Study
door: Michal Shani, et al.
Gepubliceerd in: (2018-07-01)

Efficacy and safety of intravitreal injection of conbercept for moderate to severe nonproliferative diabetic retinopathy
door: Lu Shen, et al.
Gepubliceerd in: (2024-05-01)

The relationship between the neutrophil-to-lymphocyte ratio and diabetic retinopathy in adults from the United States: results from the National Health and nutrition examination survey
door: Xiaojie He, et al.
Gepubliceerd in: (2022-08-01)

Reasons for the Late Presentation of Diabetic Retinopathy in Saudi Arabia: A Survey of Patients Who Presented with Advanced Proliferative Diabetic Retinopathy to a Tertiary Eye Hospital
door: Al-Shehri AM, et al.
Gepubliceerd in: (2022-12-01)

Exploring Diabetic Retinopathy Patterns in Saudi Arabia: Gender and Diabetes Type Comparison
door: Samraa Hussain, et al.
Gepubliceerd in: (2023-11-01)

Update on Management of Non-proliferative Diabetic Retinopathy without Diabetic Macular Edema; Is There a Paradigm Shift?
door: Amir Arabi, et al.
Gepubliceerd in: (2022-01-01)

Assessment of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and mean platelet volume in patients with diabetic retinopathy
door: Trisha Ghosh, et al.
Gepubliceerd in: (2025-01-01)

Association of monocyte-lymphocyte ratio and proliferative diabetic retinopathy in the U.S. population with type 2 diabetes
door: Huan Wang, et al.
Gepubliceerd in: (2022-05-01)

Nuclear proteins and diabetic retinopathy: a review
door: Bin Li, et al.
Gepubliceerd in: (2024-06-01)

PROGRESSION OF DIABETIC NON-PROLIFERATIVE RETINOPATHY IN TYPE 2 DIABETES MELLITUS: THE CONNECTION WITH THE BLOOD ENDOTHELIAL MONOCYTE-ACTIVATING POLYPEPTIDE-II LEVEL
door: S.O. Rykov, et al.
Gepubliceerd in: (2020-12-01)

Screening for Diabetic Retinopathy – a Twelve-Month Review
door: Tomaž Gračner
Gepubliceerd in: (2020-01-01)

Optical coherence tomography findings in patients with diabetic macular edema: A retrospective analysis
door: Manjunathan Sivarasu, et al.
Gepubliceerd in: (2025-01-01)

Novel risk score model for non-proliferative diabetic retinopathy based on untargeted metabolomics of venous blood
door: Xinyu Wang, et al.
Gepubliceerd in: (2023-08-01)

Uric Acid and Diabetic Retinopathy: A Systematic Review and Meta-Analysis
door: Yicong Guo, et al.
Gepubliceerd in: (2022-05-01)

Role of hyperhomocysteinemia in proliferative diabetic retinopathy: A case–control study
door: Prabha Gupta, et al.
Gepubliceerd in: (2018-01-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
door: Reyno Satria Ali, et al.
Gepubliceerd in: (2023-02-01)

CLINICAL CHARACTERISTICS OF PROLIFERATIVE DIABETIC RETINOPATHY (PDR) PATIENTS WITH VITREOUS HEMORRHAGE AT CIPTO MANGUNKUSUMO HOSPITAL
door: Reyno Satria Ali, et al.
Gepubliceerd in: (2023-02-01)

Natural History of Diabetic Retinopathy Through Retrospective Analysis in Type 2 Diabetic Patients—An Exploratory Study
door: Mehak Gupta, et al.
Gepubliceerd in: (2021-11-01)

Association between neutrophil-to-lymphocyte ratio and diabetic retinopathy in patients with type 2 diabetes: a cohort study
door: Yuchen Tang, et al.
Gepubliceerd in: (2024-07-01)

Metabolomic comparison followed by cross-validation of enzyme-linked immunosorbent assay to reveal potential biomarkers of diabetic retinopathy in Chinese with type 2 diabetes
door: Zongyi Wang, et al.
Gepubliceerd in: (2022-09-01)

Newly diagnosed diabetes mellitus patients presenting with proliferative diabetic retinopathy as an initial sign
door: Hoon Park, et al.
Gepubliceerd in: (2014-02-01)

Integrated Analysis of Metabolomics and Lipidomics in Plasma of T2DM Patients with Diabetic Retinopathy
door: Chun Ding, et al.
Gepubliceerd in: (2022-12-01)

Role of Vitrectomy in the Treatment of Diabetic Retinopathy
door: D. V. Petrachkov, et al.
Gepubliceerd in: (2021-10-01)